Milena Sokolowska MD, PhD, PD is the Head of the Immune Metabolism Department at the Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich. She graduated as a medical doctor (MD) in 2005 and received her doctorate (PhD) degree in medicine and immunology in 2009 from the Medical University in Lodz, Poland working on genetics and immunology of severe asthma with Prof. Rafał Pawliczak. She performed her postdoctoral studies at the Critical Care Medicine Department (CCMD), Clinical Center, National Institutes of Health, Bethesda, MD, US with Dr. James Shelhamer studying inflammasome and lipid signaling in asthma, and in 2010-2014 and the SIAF, UZH in 2014-2017 with Prof. Cezmi Akdis on mulitiomics of immune tolerance in allergy and asthma. She obtained her board certification in Internal Medicine in 2021 and habilitation in Immunology, Allergology and Pulmonology (Privatdozent, PD) from the University of Zurich in 2022. Her current research encompasses involvement of immunometabolism, respiratory viruses and microbiome in immune tolerance and in the pathogenesis of allergic, pulmonary and autoimmune diseases. She authored and co-authored more than 90 scientific publications in international journals, including Immunity, Nature Communications, Mucosal Immunology, Journal of Allergy and Clinical Immunology, Journal of Immunology, Journal of Biological Chemistry, Allergy and others. She also contributed to several textbooks in allergy, immunology and molecular biology. She is an Executive Board Member of the European Academy of Allergy and Clinical Immunology (EAACI), where she leads the Basic and Clinical Immunology Section and several task forces in EAACI, resulting in the international guidelines and position papers. She is also a member of European Respiratory Society (ERS) and Swiss Society for Allergy and Immunology (SSAI). She is an Associate Editor in Heliyon, Cell Press, Editorial Board member in Scientific Reports, Allergy and Clinical and Molecular Allergy, guest editor in Frontiers in Immunology, and a member of the Reviewers Board in Frontiers in Pharmacology and Frontiers in Allergy. Her research has been funded by the grants and fellowships from the Swiss National Science Foundation (SNFS), National Institutes of Health (NIH) Intramural Research Program, European Respiratory Society (ERS)/European Molecular Biology Organisation (EMBO), European Academy of Allergy and Clinical Immunology (EAACI), Polish State Committee for Scientific Research and third parties. She received several scientific awards including EAACI PhARF Award, Scopus Young Researcher Award, Polish Prime Minister and Minister of Health Award for best PhD thesis and scientific achievements, Journal of Biological Chemistry Paper of the Year Award, numerous international travel grants and best oral and poster presentation awards.